The Amyloid Hypothesis and Alzheimer's Disease

This chapter delves into the amyloid hypothesis, drug therapies targeting plaque reduction, the link between plaques and cognitive decline, a pivotal Nature paper from 2006, the discovery of a subtype of amyloid protein causing cognitive decline in mice, the high fail rate of Alzheimer's drug trials, and the controversy surrounding the FDA-approved drug aducanumab.